RN

Randolph J. Noelle

DC Dartmouth College: 55 patents #1 of 689Top 1%
IT Io Therapeutics: 11 patents #3 of 19Top 20%
KL King'S College London: 9 patents #1 of 368Top 1%
BS Bristol-Myers Squibb: 5 patents #1,010 of 3,969Top 30%
UC University Of Massachusetts Medical Center: 5 patents #5 of 85Top 6%
3M: 3 patents #4,214 of 11,543Top 40%
UM University Of Massachusetts: 1 patents #755 of 1,810Top 45%
TC The Trustees Of Darmouth College: 1 patents #1 of 18Top 6%
📍 Plainfield, NH: #1 of 18 inventorsTop 6%
🗺 New Hampshire: #82 of 12,181 inventorsTop 1%
Overall (All Time): #32,615 of 4,157,543Top 1%
66
Patents All Time

Issued Patents All Time

Showing 26–50 of 66 patents

Patent #TitleCo-InventorsDate
10259879 Anti-CD154 antibodies having impaired FcR binding and/or complement binding properties 2019-04-16
10201512 Autoimmune disorder treatment using RXR agonists Roshantha A. Chandraratna, Ethan Dmitrovsky, Elizabeth Nowak 2019-02-12
10105426 Immunostimulatory combinations Cory L. Ahonen, Ross Kedl 2018-10-23
10035857 Regulatory T cell mediator proteins and uses thereof Li Wang 2018-07-31
10034845 Autoimmune disorder treatment using RXR agonists Roshantha A. Chandraratna, Ethan Dmitrovsky, Elizabeth Nowak 2018-07-31
9890215 Vista modulators for diagnosis and treatment of cancer 2018-02-13
9758587 Methods of immune therapy with anti-CD154 antibodies having impaired FcR binding and/or complement binding properties 2017-09-12
9631018 Vista regulatory T cell mediator protein, vista binding agents and use thereof Lili Wang 2017-04-25
9381244 VISTA modulators for diagnosis and treatment of cancer 2016-07-05
9321833 Methods of therapy with anti-CD154 antibodies having impaired FcR binding and/or complement binding properties 2016-04-26
9238067 Methods of promoting immunity to an infectious agent by administering CD40 agonists and alpha-galactosyl ceramide Cory L. Ahonen 2016-01-19
9217035 Regulatory T cell mediator proteins and uses thereof Li Wang 2015-12-22
9161976 Immunotherapy comprising TLR9 ligand and CD40 ligand Cory L. Ahonen, Ross Kedl 2015-10-20
9028826 Methods of immune therapy with anti-CD154 antibodies having impaired FcR binding and/or complement binding properties 2015-05-12
8852597 Anti-CD154 antibodies having impaired FcR binding and/or complement binding properties 2014-10-07
8802098 Methods of promoting antitumor immunity by administering CD40 agonists and alpha-galactosyl ceramide Cory L. Ahonen 2014-08-12
8679501 Method for modulating inflammatory responses Li-Fan Lu, Cory L. Ahonen 2014-03-25
8501915 Regulatory T cell mediator proteins and uses thereof Li Wang 2013-08-06
8465740 Regulatory T cell mediator proteins and uses thereof Li-Fan Lu, Sergio Quezada, David Gondek 2013-06-18
8415154 Compositions and methods for producing adaptive regulatory T cells 2013-04-09
8329197 Ex vivo uses of immunostimulatory combinations Cory L. Ahonen, Ross Kedl 2012-12-11
8236304 Use of PD-L3 proteins and PD-L3 specific antibodies or antibody fragments to regulate CD4+ and CD8+ T cell immunity Li-Fan Lu, Sergio Quezada, David Gondek 2012-08-07
8231872 Regulatory T cell mediator proteins and uses thereof Li Wang 2012-07-31
7993659 TLR9 agonist and CD40 agonist immunostimulatory combinations Cory L. Ahonen, Ross Kedl 2011-08-09
7722874 Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells Teresa Foy, Fiona H. Durie 2010-05-25